On these premises, the current study was undertaken to examine the clinical features and biomarkers of skin biopsy-diagnosed SFN-positive (+) patients with UA developed after PC or PCV syndromes, in comparison to SFN-negative (−) patients with similar new-onset PC- and PCV-associated lower limb paresthesia. The gene discussed is SFN; the disease is pachyonychia congenita.